C
34.52
0.27 (0.77%)
| Previous Close | 34.25 |
| Open | 34.74 |
| Volume | 1,315,733 |
| Avg. Volume (3M) | 12,521,179 |
| Market Cap | 16,964,744,192 |
| Price / Earnings (Forward) | 12.22 |
| Price / Sales | 0.100 |
| Price / Book | 0.870 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bearish |
| Healthcare Plans (Global) | Bullish | Bearish | |
| Stock | Centene Corporation | Bullish | Bearish |
AIStockmoo Score
1.9
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 1.88 |
|
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Jun 2025 | 8,043,255 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 45.00 (Truist Securities, 30.38%) | Buy |
| Median | 38.00 (10.10%) | |
| Low | 34.00 (TD Cowen, -1.49%) | Hold |
| Average | 39.18 (13.52%) | |
| Total | 2 Buy, 8 Hold, 1 Sell | |
| Avg. Price @ Call | 35.22 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 12 Nov 2025 | 35.00 (1.41%) | Hold | 36.20 |
| 07 Oct 2025 | 41.00 (18.79%) | Hold | 38.42 | |
| Barclays | 04 Nov 2025 | 44.00 (27.48%) | Hold | 36.11 |
| 12 Sep 2025 | 35.00 (1.41%) | Hold | 33.26 | |
| JP Morgan | 04 Nov 2025 | 38.00 (10.10%) | Hold | 36.11 |
| Goldman Sachs | 31 Oct 2025 | 38.00 (10.10%) | Sell | 35.37 |
| 14 Oct 2025 | 33.00 (-4.39%) | Sell | 36.44 | |
| TD Cowen | 31 Oct 2025 | 34.00 (-1.49%) | Hold | 35.37 |
| Cantor Fitzgerald | 30 Oct 2025 | 41.00 (18.79%) | Hold | 35.02 |
| 26 Aug 2025 | 38.00 (10.10%) | Hold | 28.66 | |
| Truist Securities | 30 Oct 2025 | 45.00 (30.38%) | Buy | 35.02 |
| 12 Sep 2025 | 39.00 (12.99%) | Buy | 33.26 | |
| UBS | 30 Oct 2025 | 42.00 (21.69%) | Hold | 35.02 |
| Morgan Stanley | 14 Oct 2025 | 38.00 (10.10%) | Hold | 36.44 |
| Mizuho | 09 Oct 2025 | 40.00 (15.89%) | Hold | 37.83 |
| Bernstein | 05 Sep 2025 | 36.00 (4.30%) | Buy | 28.98 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |